Stryker Corp (SYK): Cost of Revenue
$9.05B
Year ended 2025-12-31
$9.05B
Trailing 12 months to 2026-06-30
+9.6%
3-year compound annual growth
+11.3%
5-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $9.05B | +11.0% | 2026-02-11, From 2025-01-01 |
| 2024-12-31 | $8.15B | +9.6% | 2026-02-11, From 2024-01-01 |
| 2023-12-31 | $7.44B | +8.3% | 2026-02-11, From 2023-01-01 |
| 2022-12-31 | $6.87B | +11.9% | 2025-02-12, From 2022-01-01 |
| 2021-12-31 | $6.14B | +16.0% | 2024-02-14, From 2021-01-01 |
| 2020-12-31 | $5.29B | +2.0% | 2023-02-10, From 2020-01-01 |
| 2019-12-31 | $5.19B | +11.3% | 2022-02-11, From 2019-01-01 |
| 2018-12-31 | $4.66B | +9.4% | 2021-02-11, From 2018-01-01 |
| 2017-12-31 | $4.26B | +11.6% | 2020-02-06, From 2017-01-01 |
| 2016-12-31 | $3.82B | n/a | 2019-02-07, From 2016-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Stryker Corp (SYK) | 2025-12-31 | $9.05B | +11.0% |
| 3M Co (MMM) | 2025-12-31 | $14.99B | +3.8% |
| Medline Inc. (MDLN) | 2025-12-31 | $20.91B | +12.9% |
| Becton Dickinson & Co (BDX) | 2025-09-30 | $11.91B | +7.8% |
| Boston Scientific Corp (BSX) | 2025-12-31 | $6.22B | +18.3% |
| Baxter International Inc (BAX) | 2025-12-31 | $7.87B | +18.2% |
| ResMed Inc (RMD) | 2026-06-30 | $2.20B | +5.3% |
| Dexcom Inc (DXCM) | 2025-12-31 | $1.86B | +16.6% |
| MiniMed Group, Inc. (MMED) | 2026-04-24 | $1.42B | +19.8% |
Compare SYK, MMM, MDLN, BDX side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗